Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
IFA Incomplete Freund's Adjuvant
BIOLOGICAL
2 trials
Sponsors
Immune Response BioPharma, Inc.
Conditions
Multiple Sclerosis
Phase 1
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis
NCT02200718
Immune Response BioPharma, Inc.
Multiple Sclerosis
Start: 2020-12-31
End: 2024-11-09
Target: 12
Updated: 2020-03-31
Phase 2
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
NCT02149706
Immune Response BioPharma, Inc.
Multiple Sclerosis
Start: 2020-03-09
End: 2022-03-09
Target: 150
Updated: 2020-03-11